MergerLinks Header Logo

Submit Deal

Submit Deal

Announced

Completed

SOBI completed the acquisition of a 60% stake in Pint Pharma International from Farallon Capital-backed Pintador for $105m.

Synopsis

SOBI, a biopharmaceutical and biotechnology company, completed the acquisition of a 60% stake in Pint Pharma International, a biopharmaceutical company, from Farallon Capital-backed Pintador, a holding company, $105m.

Principals

Pint Pharma International

target

Pint Pharma International

Swedish Orphan Biovitrum (sobi)

bidder

Swedish Orphan Biovitrum (sobi)

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

Market Context

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2026 Datasite

MergerLinks - SOBI completed the acquisition of a 60% stake in Pint Pharma International from Farallon Capital-backed Pintador for $105m.